Helvaci, B. C. Et Al. 2024. Novel Homozygous Variant in the SLC19A2 Gene Causing Thiamine Responsive Megaloblastic Anemia Syndrome: A Disease to Be Considered in Diabetes Clinics. ENDOCRINOLOGY RESEARCH AND PRACTICE , no.4 , 236-239.

Helvaci, B. C., Saat, H., Hepsen, S., HELVACI, Ö., & Cakal, E., (2024). Novel Homozygous Variant in the SLC19A2 Gene Causing Thiamine Responsive Megaloblastic Anemia Syndrome: A Disease to Be Considered in Diabetes Clinics. ENDOCRINOLOGY RESEARCH AND PRACTICE , no.4, 236-239.

Helvaci, Burcak Et Al. "Novel Homozygous Variant in the SLC19A2 Gene Causing Thiamine Responsive Megaloblastic Anemia Syndrome: A Disease to Be Considered in Diabetes Clinics," ENDOCRINOLOGY RESEARCH AND PRACTICE , no.4, 236-239, 2024

Helvaci, Burcak C. Et Al. "Novel Homozygous Variant in the SLC19A2 Gene Causing Thiamine Responsive Megaloblastic Anemia Syndrome: A Disease to Be Considered in Diabetes Clinics." ENDOCRINOLOGY RESEARCH AND PRACTICE , no.4, pp.236-239, 2024

Helvaci, B. C. Et Al. (2024) . "Novel Homozygous Variant in the SLC19A2 Gene Causing Thiamine Responsive Megaloblastic Anemia Syndrome: A Disease to Be Considered in Diabetes Clinics." ENDOCRINOLOGY RESEARCH AND PRACTICE , no.4, pp.236-239.

@article{article, author={Burcak Cavnar Helvaci Et Al. }, title={Novel Homozygous Variant in the SLC19A2 Gene Causing Thiamine Responsive Megaloblastic Anemia Syndrome: A Disease to Be Considered in Diabetes Clinics}, journal={ENDOCRINOLOGY RESEARCH AND PRACTICE}, year=2024, pages={236-239} }